John D Halpern - Net Worth and Insider Trading

John D Halpern Net Worth

The estimated net worth of John D Halpern is at least $1 Million dollars as of 2024-05-15. John D Halpern is the 10% Owner of Eterna Therapeutics Inc and owns about 451,166 shares of Eterna Therapeutics Inc (ERNA) stock worth over $1 Million. Details can be seen in John D Halpern's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John D Halpern has not made any transactions after 2022-12-02 and currently still holds the listed stock(s).

Transaction Summary of John D Halpern

To

John D Halpern Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John D Halpern owns 1 companies in total, including Eterna Therapeutics Inc (ERNA) .

Click here to see the complete history of John D Halpern’s form 4 insider trades.

Insider Ownership Summary of John D Halpern

Ticker Comapny Transaction Date Type of Owner
ERNA Eterna Therapeutics Inc 2022-12-02 10 percent owner

John D Halpern Latest Holdings Summary

John D Halpern currently owns a total of 1 stock. John D Halpern owns 451,166 shares of Eterna Therapeutics Inc (ERNA) as of December 2, 2022, with a value of $1 Million.

Latest Holdings of John D Halpern

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ERNA Eterna Therapeutics Inc 2022-12-02 451,166 2.35 1,060,285

Holding Weightings of John D Halpern


John D Halpern Form 4 Trading Tracker

According to the SEC Form 4 filings, John D Halpern has made a total of 1 transactions in Eterna Therapeutics Inc (ERNA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eterna Therapeutics Inc is the acquisition of 335,920 shares on December 2, 2022, which cost John D Halpern around $1 Million.

Insider Trading History of John D Halpern

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John D Halpern Trading Performance

GuruFocus tracks the stock performance after each of John D Halpern's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John D Halpern is 13.64%. GuruFocus also compares John D Halpern's trading performance to market benchmark return within the same time period. The performance of stocks bought by John D Halpern within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John D Halpern's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John D Halpern

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.42
Relative Return to S&P 500(%) 3.28

John D Halpern Ownership Network

Ownership Network List of John D Halpern

No Data

Ownership Network Relation of John D Halpern


John D Halpern Owned Company Details

What does Eterna Therapeutics Inc do?

Who are the key executives at Eterna Therapeutics Inc?

John D Halpern is the 10 percent owner of Eterna Therapeutics Inc. Other key executives at Eterna Therapeutics Inc include 10 percent owner Charles Cherington , 10 percent owner Freebird Investments Llc , and 10 percent owner Freebird Partners Lp .

Eterna Therapeutics Inc (ERNA) Insider Trades Summary

Over the past 18 months, John D Halpern made 1 insider transaction in Eterna Therapeutics Inc (ERNA) with a net purchase of 335,920. Other recent insider transactions involving Eterna Therapeutics Inc (ERNA) include a net purchase of 283,286 shares made by Nicholas Jason Singer , a net purchase of 261,756 shares made by Charles Cherington ,

In summary, during the past 3 months, insiders sold 0 shares of Eterna Therapeutics Inc (ERNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eterna Therapeutics Inc (ERNA) were sold and 880,962 shares were bought by its insiders, resulting in a net purchase of 880,962 shares.

Eterna Therapeutics Inc (ERNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eterna Therapeutics Inc Insider Transactions

No Available Data

John D Halpern Mailing Address

Above is the net worth, insider trading, and ownership report for John D Halpern. Currently GuruFocus does not have mailing address information for John D Halpern.

Discussions on John D Halpern

No discussions yet.